HLA-A*1101 & B2M & HPV16-E6 (TTLEQQYNK)

HLA-A*1101 & B2M & HPV16-E6 (TTLEQQYNK) Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
His Tag (1)
Marqueur
PE Labeled (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
HLH-HP2H4	Human	HEK293	PE-Labeled Human HLA-A*11:01&B2M&HPV16-E6 (TTLEQQYNK) Tetramer Protein				Ajouter au panier

Quantité totale1

HLA-A*1101 & B2M & HPV16-E6 (TTLEQQYNK)Contexte de la molécule

Human papillomavirus (HPV) is A kind of papillomavirus belonging to the milk polypoid virus family. It is a spherical D virus, which can cause the proliferation of squamous epithelium of human skin mucosa. HPV(human papillomavirus) for common warts, genital warts (condyloma acuminatum), and other symptoms. There are many types of human papillomavirus (HPV), with HPV 16 and 18 being high-risk types known to significantly increase the risk of cervical, vaginal and vulvar cancers in women and men. The PE-labeled human HLA-A*1101 HPV (TTLEQQYNK) tetramer protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and TTLEQQYNK peptide of the HPV.

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
Mavrilimumab	CAM-3001; KPL-301; GM-CSFR; CAM3001	Phase 3 Clinical	Csl Ltd	Pneumonia; Giant Cell Arteritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)	Details
CSF2RA gene-corrected macrophages(University of South Florida)		Phase 2 Clinical	Russian Academy Of Medical Sciences	Pulmonary Alveolar Proteinosis	Details
STSA-1005	STSA-1005; STSA1005	Phase 1 Clinical		Coronavirus Disease 2019 (COVID-19)	Details